Sunday, February 12, 2012
Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

All SharePosts Relating To "NAMI"

Expert_badge Robin Cunningham

Robin Cunningham

(Profile)
Advocate and Executive

NAMI 2007 Convention: An Interview with Jonathan Stanley

Johnathan Stanley Jonathan Stanley, J.D., is the Acting Executive Director of the Treatment Advocacy Center (TAC), which is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental disorders. After the onset of bipolar disorder, he graduated from law school, was a practicing... Read moreChevron
posted 09/09/2007, comments (0)|
Expert_badge Robin Cunningham

Robin Cunningham

(Profile)
Advocate and Executive

NAMI 2007 Convention: Interview with E. Fuller Torrey

E. Fuller Torrey, M.D.  This is number five in a series of blogs made possible by the encouragement and financial support of The HealthCentral Network. All represent interviews with senior officers of NAMI [National Alliance on Mental Illness] or other luminaries that attended the NAMI 2007 annual convention. These interviews cover a... Read moreChevron
Expert_badge Robin Cunningham

Robin Cunningham

(Profile)
Advocate and Executive

FDA Approves Risperdal for the Treatment of Schizophrenia and Bipolar Disorder in Children

The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event. The decision was apparently made on the basis of a few very short term studies populated by a small number of subjects, a decision which is most uncharacteristic of the FDA. I have a number of acquaintances... Read moreChevron
Expert_badge Robin Cunningham

Robin Cunningham

(Profile)
Advocate and Executive

NAMI 2007 Convention: Interview with Lynn Borton

Lynn Borton  This is number four in a series of seven blogs made possible by the encouragement and financial support of The HealthCentral Network. All represent interviews with senior officers of NAMI [National Alliance on Mental Illness] or other luminaries that attended the NAMI 2007 annual convention. These interviews cover a wide... Read moreChevron
posted 08/19/2007, comments (0)|
Expert_badge Robin Cunningham

Robin Cunningham

(Profile)
Advocate and Executive

The FDA / DDMAC Request that Pfizer Discontinue use of an Ad for Geodon for Injection

 I have reviewed materials available to me concerning the recent request by the Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA) that Pfizer discontinue its use of an ad placed in a professional journal for Geodon (ziprasidone mesylate) for injection. These materials included a... Read moreChevron
posted 08/16/2007, comments (0)|

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (1460) >